神经重症监护单元中经验性使用哌拉西林-他唑巴坦患者出现血小板功能障碍与脑出血
一例55岁越南男性高血压患者因颅内出血接受脑室外引流及四腔螺栓置入,围手术期血小板功能检测正常且术后影像无出血。因高度怀疑吸入性肺炎经验性使用哌拉西林-他唑巴坦后,分别在拔除四腔螺栓及脑室外引流的复查CT均显示器械通道新发血肿伴显著脑室内出血,复查血小板功能检测异常延长,停药6小时后血小板功能检测呈正常化趋势并逐渐恢复至基线。作者认为出血归因于血小板功能障碍而非血小板减少,这是首例可能与应用哌拉西林-他唑巴坦相关的颅内围手术期出血报告,需进一步研究该药对血小板定性功能的影响。
要点
- 经验性哌拉西林-他唑巴坦使用后,拔除颅内器械的复查CT均显示通道新发血肿伴脑室内出血。
- 出血归因于血小板功能障碍而非血小板减少,复查血小板功能检测较基线异常延长。
- 停药6小时后血小板功能检测呈正常化趋势,此后逐渐恢复至基线。
核心结论
- 作者认为本例显著出血归因于血小板功能障碍而非血小板减少。
- 作者指出这是首例可能与应用哌拉西林-他唑巴坦相关的颅内围手术期出血报告。
- 作者认为需进一步研究该药对血小板定性功能的影响。
研究设计与样本
- 单个病例报告,患者为55岁越南男性,有高血压,因颅内出血接受治疗。
主要发现
- 脑室外引流及四腔螺栓置入时血小板功能检测正常,置入后影像未见出血。
- 因高度怀疑吸入性肺炎经验性使用哌拉西林-他唑巴坦。
- 分别拔除四腔螺栓和脑室外引流后,两次复查CT均显示器械通道新发血肿伴显著脑室内出血。
- 复查血小板功能检测异常延长,较基线有明确变化。
- 停用哌拉西林-他唑巴坦6小时后观察到血小板功能检测正常化趋势,此后逐渐恢复至基线。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Piperacillin-tazobactam is common empiric antibiotic therapy. Hematologic laboratory test abnormalities were documented but rare in premarketing studies, and whether these alterations are of clinical significance has been studied little. Very few cases of piperacillin-induced bleeding, thrombocytopenia, or both have been reported; aberrations in platelet function have not been implicated. CASE DESCRIPTION: A 55-year old Vietnamese man with hypertension presented for treatment of an Intracranial hemorrhage. Platelet function assays (PFAs) at the time of external ventricular drain and quad-lumen bolt placement were normal, and imaging showed no hemorrhage after placement. The patient was later started on empiric piperacillin-tazobactam due to high suspicion for aspiration pneumonia. After removal of the quad-lumen bolt and external ventricular drain on separate days, both follow-up computed tomography scans showed new hematomas in the devices' tracts, with significant intraventricular hemorrhage. Repeat PFAs were abnormally prolonged, representing a distinct change from baseline. A trend toward normalization of PFAs was observed 6 hours after discontinuation of piperacillin-tazobactam with progression toward baseline thereafter. CONCLUSIONS: This is unique in that the significant bleeding that occurred was attributable to platelet dysfunction rather than thrombocytopenia. This is the first reported case of intracranial (periprocedural) hemorrhage potentially related to piperacillin-tazobactam; further research into this drug's impact upon qualitative platelet function is needed.
引用
- Bower M, Borders C, Schnure A, et al. Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit. World Neurosurg. 2018. PMID: 29555607. doi:10.1016/j.wneu.2018.03.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。